The Impact of Precision Medicine on Modern Healthcare: A Discussion with Dr. Sandy Milligan

Personalized medicine still has so much potential. With the need for greater adoption and further advancement becoming more apparent, this conversation is necessary.

Today's guest is Dr. Sandy Milligan, the President of Research & Development, Laboratory Operations, IT and HR at Aspira Women’s Health. Dr. Milligan explains the nuances of personalized medicine, defining it as an individualized approach to healthcare that leverages precise diagnostics based on omics data analytics. We explore the challenges and opportunities in adopting personalized medicine, particularly in the United States, and discuss the financial, regulatory, and clinical hurdles that need to be overcome.

Dr. Milligan shares insightful examples from the fields of hypertension and oncology, highlighting how personalized medicine can revolutionize treatment plans and improve patient outcomes. We also delve into the critical role of biomarkers in developing innovative therapies and diagnostics, especially for complex diseases like endometriosis and various cancers.

Tune in to learn about the current state and future potential of personalized medicine from one of the leading experts in the field!

—----

Stay connected with our host, Perry Dimas, here on LinkedIn!